Coloplast A/S (OTCMKTS:CLPBY) Sets New 1-Year Low – Should You Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBYGet Free Report) hit a new 52-week low during trading on Thursday . The company traded as low as $6.59 and last traded at $6.6380, with a volume of 58717 shares trading hands. The stock had previously closed at $6.85.

Wall Street Analyst Weigh In

Separately, Sanford C. Bernstein raised Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

Check Out Our Latest Stock Report on CLPBY

Coloplast A/S Stock Down 1.3%

The company has a debt-to-equity ratio of 1.50, a current ratio of 1.30 and a quick ratio of 0.81. The firm has a market capitalization of $14.83 billion, a P/E ratio of 24.37, a price-to-earnings-growth ratio of 0.67 and a beta of 0.33. The business has a 50 day moving average price of $7.85 and a 200 day moving average price of $8.63.

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) last announced its earnings results on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%. On average, analysts predict that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

About Coloplast A/S

(Get Free Report)

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.

Further Reading

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.